Carson Wealth (CWM LLC)
IPSC icon

Carson Wealth (CWM LLC)’s Century Therapeutics IPSC Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-254
Closed – – 5496
2025
Q3 		$0 Sell
254
-7,897
-97% -$4.26K ﹤0.01% 5401
2025
Q2 		$5K Buy
8,151
+1,302
+19% +$699 ﹤0.01% 4619
2025
Q1 		$3K Buy
6,849
+5,371
+363% +$4.04K ﹤0.01% 4633
2024
Q4 		$1K Buy
1,478
+1,379
+1,393% +$1.88K ﹤0.01% 4726
2024
Q3 		$0 Buy
99
+73
+281% +$143 ﹤0.01% 4973
2024
Q2 		$0 Buy
26
+24
+1,200% +$76 ﹤0.01% 4743
2024
Q1 		$0 Buy
+2
New +$8 ﹤0.01% 4515
2023
Q4 		– Sell
-45
Closed – – 4323
2023
Q3 		$0 Buy
+45
New +$120 ﹤0.01% 4334

Other funds holding IPSC

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Carson Wealth (CWM LLC)'s IPSC Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Century Therapeutics (IPSC) in Q4 2025, closing a stake of 254 shares.

Carson Wealth (CWM LLC) first reported a position in IPSC in Q3 2023 and held it in 8 quarters. The position peaked at $5K in Q2 2025. 47 funds tracked by Wall St. Rank hold IPSC as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining Century Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 254 Century Therapeutics shares in Q4 2025.
  • Carson Wealth (CWM LLC) first reported a position in Century Therapeutics in Q3 2023 and held it in 8 quarters.
  • Carson Wealth (CWM LLC)'s Century Therapeutics position peaked at $5K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.